Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lineage Cell Therapeutics, Inc. | 1,050,000 | reported | 05 Mar 2026 | tx 7+3,625,500 |
| PROGENITY, INC. | 12,500 | reported | 05 Jun 2024 | tx 9+454,597−19 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 1,050,000 | 0.00 USD | deriv |
| 10 Mar 2025 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 750,000 | 0.00 USD | deriv |
| 26 Nov 2024 | PURCHASE | Lineage Cell Therapeutics, Inc. | 15,000 | 0.59 USD | |
| 16 Aug 2024 | PURCHASE | Lineage Cell Therapeutics, Inc. | 10,500 | 0.89 USD | |
| 05 Jun 2024 | GRANT_AWARD | PROGENITY, INC. | 12,500 | 0.00 USD | |
| 05 Jun 2024 | GRANT_AWARD | PROGENITY, INC. | 12,500 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 650,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | PROGENITY, INC. | 12,500 | 0.00 USD | |
| 14 Jun 2023 | GRANT_AWARD | PROGENITY, INC. | 12,500 | 0.00 USD | deriv |
| 09 Mar 2023 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 03 Jan 2023 | OTHER | PROGENITY, INC. | 19 | — | |
| 14 Nov 2022 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 1,000,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | PROGENITY, INC. | 96,154 | 0.00 USD | |
| 15 Jun 2022 | GRANT_AWARD | PROGENITY, INC. | 148,810 | 0.00 USD | deriv |
| 03 Nov 2021 | GRANT_AWARD | PROGENITY, INC. | 76,754 | 0.00 USD | |
| 03 Nov 2021 | GRANT_AWARD | PROGENITY, INC. | 82,879 | 0.00 USD | deriv |